Aktienanalyse zu Relx PLC (RELX)RELXRelx PLC

RELX PLC is a United Kingdom-based global provider of information-based analytics and decision tools for professional and business customers. The Company operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions. It operates in the Technology sector (BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED industry).

RELX PLC is a good buy right now due to its strong financial performance, with a current price of 36.54 and a forward P/E ratio of 17.64, indicating reasonable valuation relative to future earnings. Additionally, the company reported a 3% revenue growth to £4.87 billion in the first half of 2026, along with an 8% increase in earnings per share, which enhances investor confidence. The main risk is the year-to-date change of -8.19%, reflecting market volatility, but the overall positive sentiment from analysts and hedge funds buying at a rate of 147.40% suggests a favorable outlook for long-term investors.

1 analysts cover RELX: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 60.54.